Home » News » India » NTAGI Panel Recommends Use of Covid Vaccines Corbevax, Covaxin for Kids Aged 5-12 Years
1-MIN READ

NTAGI Panel Recommends Use of Covid Vaccines Corbevax, Covaxin for Kids Aged 5-12 Years

PTI

Last Updated: July 08, 2022, 23:14 IST

New Delhi

A healthcare worker administers a dose of the Covid-19 preventive vaccine to a student in the age group of 12-14 years, at a school in Rajasthan. (Image: PTI Photo/File)

A healthcare worker administers a dose of the Covid-19 preventive vaccine to a student in the age group of 12-14 years, at a school in Rajasthan. (Image: PTI Photo/File)

However, there was no decision on introducing these vaccines in the vaccination programme

The NTAGI's Standing Technical Sub-Committee (STSC) approved the use of COVID-19 vaccines Corbevax and Covaxin for children aged between five and 12 years, official sources said on Friday. However, there was no decision on introducing these vaccines in the vaccination programme.

Data of Biological E's Corbevax and Bharat Biotech's Covaxin for children aged between five and 12 years were reviewed in the STSC meeting held on June 16 and members decided that the vaccines can be recommended for administering in children. The members, however, opined that data of Covid burden and mortality among children is not robust enough to take any decision to begin vaccination of those below 12 years, an official source said.

The issue is likely to be discussed in the next meeting. India's drug regulator in April this year had granted emergency use authorisation to Corbevax for those aged five to 12 years and Covaxin for children in the age group of six to 12 years.

Read all the Latest News, Breaking News, watch Top Videos and Live TV here.

first published:July 08, 2022, 23:14 IST
last updated:July 08, 2022, 23:14 IST